Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-care transition services for sickle cell disease in Brazil.
Hankins JS, Lobo C, Braga JAP, Aurora T, Pimenta K, Figueiredo MS, Baumann AA. Hankins JS, et al. Among authors: figueiredo ms. Lancet Haematol. 2024 Mar;11(3):e184-e185. doi: 10.1016/S2352-3026(24)00043-7. Lancet Haematol. 2024. PMID: 38428445 No abstract available.
Consensus of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) and the Brazilian Ministry of Health - General management of blood and blood products on the tests necessary for the release of exceptional medicines for sickle cell disease.
Lobo C, Araújo A, Antunes AA, Pinto ACS, Godinho AC, Pires CSM, Matheus CC, Albuquerque X, Neves DCF, Moreno FL, Baldanzi G, Siufi GC, Miranda HHP, Hankins J, Aragão J, Braga JAP, Martins JTN, Souza LCCM, Figueiredo MS, Oliveira MR, Cardoso PSR, Pinto PCA, Moura PG, Cançado RD, Araujo PIC, Saad SO, Loggetto SR, Fonseca TCC. Lobo C, et al. Among authors: figueiredo ms. Hematol Transfus Cell Ther. 2024 Jan-Mar;46(1):67-71. doi: 10.1016/j.htct.2024.01.001. Epub 2024 Feb 1. Hematol Transfus Cell Ther. 2024. PMID: 38326179 Free PMC article.
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW; ICA-17043-10 Study Investigators. Ataga KI, et al. Br J Haematol. 2011 Apr;153(1):92-104. doi: 10.1111/j.1365-2141.2010.08520.x. Epub 2011 Feb 17. Br J Haematol. 2011. PMID: 21323872 Free article. Clinical Trial.
Sickle Cell Disease in Brazil: Current Management.
da Silva Araújo A, Silva Pinto AC, de Castro Lobo CL, Figueiredo MS, Menosi Gualandro SF, Olalla Saad ST, Cançado RD. da Silva Araújo A, et al. Among authors: figueiredo ms. Hemoglobin. 2024 Apr 25:1-13. doi: 10.1080/03630269.2024.2344790. Online ahead of print. Hemoglobin. 2024. PMID: 38663998 Review.
Effects of Supplementation of Murici (Byrsonima crassifolia) and Taperebá (Spondias mombin) Pulp Extracts on Food Intake, Body Parameters, and Oxidative Stress Markers in Healthy Rats.
Almeida CORP, Martinez RM, Souza VR, Lima TPB, Nascimento BA, Noblat GA, Abreu GM, Pereira AD, Figueiredo MS, Teodoro AJ. Almeida CORP, et al. Among authors: figueiredo ms. J Med Food. 2024 Jan;27(1):47-59. doi: 10.1089/jmf.2022.0158. Epub 2023 Dec 29. J Med Food. 2024. PMID: 38156814
184 results